Patients should be counseled never to administer extra doses to make up for missed doses, as this could increase the risk of adverse effects without providing additional therapeutic benefit
Chu X, Di C, Chang P, Li L, Feng Z, Xiao S, et al
Platinum-based chemotherapeutic agents, including first-generation cisplatin, second-generation carboplatin and nedaplatin, third-generation oxaliplatin and lobaplatin, as well as novel platinum agents (e.g., ormaplatin, satraplatin), exert their antineoplastic effects primarily by targeting nuclear DNA
Testing documentation is published once results are finalized and reviewed
Lack of exercise is a major cause of chronic diseases
The adverse effects of the other cannabinoids that are becoming popular (e.g., CBD, CBG, CBN) are less well-known